Approved Study Database
Ref. No. | Scientific Title | Principal investigator |
---|---|---|
2022.194 | Clinical outcome of Territory-wide Prehospital Stroke Notification in Hong Kong |
Dr. IP Bonaventure Yiu Ming 葉曜明 |
2022.196 | Genetic Landscape of Paediatric Idiopathic Steroid-Resistant Nephrotic Syndrome (SRNS) and Congenital or Infantile Nephrotic Syndrome (NS) in Hong Kong: A Retrospective Review | Dr. CHEUNG Hon Ming |
2022.170 | A prospective cross-sectional multi-center study to assess the diagnostic accuracy of a panel of bacterial gene markers (M3) for colorectal advanced neoplasia |
Prof. LAU Louis Ho Shing 柳浩城 |
2022.207 | The impact of early-life exposure to metabolic abnormalities on pubertal development - from epidemiological analyses to mechanisms |
Prof. MA Ronald Ching Wan 馬青雲 |
2022.191 | Endovascular Embolization of Cerebral Arteriovenous Malformation, Cerebral Aneurysms, Dural Arteriovenous Fistula, and other Vascular Pathologies in Neurosurgery | Dr. CHEUNG Yuk Hong Eric |
2022.179 | Efficacy of digitally delivered and face-to-face group cognitive behavioural therapy for insomnia in pregnant women with comorbid insomnia and depression: A randomised controlled trial | Dr. CHAN Joey Wing Yan |
2022.195 | Individual Barriers & Reacceptance to Metabolic and Bariatric Surgery in Chinese Morbid Obesity Patients |
Dr. NG Stephen Ka Kei 吳家琦 |
2022.178 | Enhancing global self-esteem of breast cancer survivors: a randomized controlled trial | Prof. CHAIR Sek Ying |
2022.169 | The use of JAK-1/3 inhibitor (Tofacitinib) in Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis – A pilot study |
Dr. CHAN Agnes Wai Sze 陳慧詩醫生 |
2022.171 | A phase 3, multicenter, randomized, double-blind, placebo-controlled trial comparing the efficacy and safety of tafasitamab plus lenalidomide in addition to R-CHOP versus R-CHOP in previously untreated, high-intermediate and high-risk patients with newly-diagnosed diffuse large B-cell lymphoma (DLBCL) |
Dr. WONG Raymond Siu Ming 王紹明 |
2022.167 | Telemedicine for out-patient management of adult asthma patients, effect on quality of life and asthma control, a randomised control trial. |
Dr. KO Fanny Wai San 古惠珊 |
2022.166 | Diagnostic utility of Mycobacterium tuberculosis cell-free DNA (MTB cfDNA) in tuberculous and non-tuberculous pleural effusion |
Dr. CHAN Ka Pang 陳嘉鵬 |
2022.165 | A prospective study to identify known and unknown bacterial pathogens in patients with pleural infections using a combination of conventional culture and next-generation sequencing approaches |
Dr. CHAN Ka Pang 陳嘉鵬 |
2022.172 | KontRASt-02: A randomized, controlled, open label, phase III study evaluating the efficacy and safety of JDQ443 versus docetaxel in previously treated subjects with locally advanced or metastatic KRAS G12C mutant non-small cell lung cancer |
Dr. LOONG Herbert Ho Fung 龍浩鋒醫生 |
2022.173 | EPIK-B3: A Phase III, multicenter, randomized, double-blind, placebo-controlled study to assess the efficacy and safety of alpelisib (BYL719) in combination with nab-paclitaxel in patients with advanced triple negative breast cancer with either phosphoinositide-3-kinase catalytic subunit alpha (PIK3CA) mutation or phosphatase and tensin homolog protein (PTEN) loss without PIK3CA mutation |
Prof. YEO Winnie 楊明明教授 |
2022.164 | A Study on Outcomes of Surgical and Percutaneous Left Atrial Appendage Closure |
Prof. YAN Bryan Ping Yen 甄秉言 |
2022.180 | Melanopsin-mediated pupillary response in patients with rapid eye movement sleep behaviour disorder | Dr. CHAN Joey Wing Yan |
2022.181 | Evaluation the effects of an online sleep and mood intervention in adults recovered from COVID-19 |
Dr. CHAN Ngan Yin 陳銀燕 |
2022.163 | Unraveling the regulatory effects of prodrug epigallocatechin-3-gallate on myeloid-derived suppresser cells to suppress the development of endometriosis |
Dr. ZHANG Tao 張濤 |
2022.201 | Territory-wide Retrospective Cohort Review of Paediatric Cardiomyopathy in Hong Kong | Dr. SO Enoch Chi Tak |
2022.182 | A Phase 2 Open-label Extension Study for Subjects with Prostate Cancer Who Previously Participated in an Enzalutamide Clinical Study |
Prof. NG Chi Fai 吳志輝 |
2022.175 | Sequential TransArterial chemoembolization and stereotactic RadioTherapy Followed by Durvalumab (MEDI4736) and Tremelimumab for downstaging hepatocellular carcinoma for hepatectomy |
Prof. CHAN Stephen Lam 陳林醫生 |
2022.174 | AN OPEN LABEL, RANDOMISED, PHASE 2 STUDY TO EVALUATE THE SAFETY AND EFFICACY OF MTL-CEBPA ADMINISTERED IN COMBINATION WITH SORAFENIB OR SORAFENIB ALONE, IN TKI NAÏVE PARTICIPANTS WITH PREVIOUSLY TREATED ADVANCED HEPATOCELLULAR CARCINOMA (HCC) AND HEPATITIS B OR HEPATITIS C VIRUS (OUTREACH2) |
Prof. CHAN Stephen Lam 陳林 |
2022.162 | A Multicenter, Cross-sectional Study to Characterize the Distribution of Lipoprotein(a) Levels Among Patients With Documented History of Atherosclerotic Cardiovascular Disease (ASCVD) |
Prof. YAN Bryan Ping Yen 甄秉言教授 |
2022.197 | Excess all-cause mortality during the COVID-19 pandemic in Hong Kong: A time series analysis using territory-wide hospitalization data | Dr. CHONG Ka Chun |
2022.198 | An audit of clinical outcomes of otology and neurotology surgeries in Hong Kong |
Dr. NG Iris Hoi Yee 伍凱怡 |
2022.183 | Online Mindfulness-based Intervention to Enhance Bracing Compliance for Adolescent Idiopathic Scoliosis (AIS) – A Pilot Randomized Single-blinded Controlled Trial |
Prof. LAM Tsz Ping 林子平 |
2022.202 | Real world analysis of sequencing of systemic treatment in hepatocellular carcinoma |
Prof. CHAN Stephen L. 陳林 |
2022.231 | A retrospective study on parental decisions following positive non-invasive prenatal testing of sex chromosome aneuploidies in Hong Kong | Prof. CHOY Kwong Wai |
2022.229 | Utilization of prenatal chromosomal microarray analysis (CMA) in prenatal diagnosis in Hong Kong | Prof. CHOY Kwong Wai |
2022.230 | Evaluation of clinical impact of public funded second-tier non-invasive prenatal testing (NIPT) in Hong Kong | Prof. CHOY Kwong Wai |
2022.203 | Altered gut microbiome composition by appendectomy contributes to colorectal cancer |
Prof. YU Jun 于君 |
2022.184 | Efficacy and Safety of an innovative Chinese Herbal formular for the Treatment of Gout: A Double-blind, Randomized, Placebo-Controlled Trial 一個創新中藥方劑作為治療痛風症之療效及安全性研究:隨機、雙盲、安慰劑對照臨床試驗 |
Prof. LIN Zhixiu 林志秀 |
2022.204 | Evalution of the Progression of Disease and Health-related Quality of Life in Ambulatory Heart Failure Patients: A local clinic-based registry |
Prof. TAN Guang Ming 譚廣明 |
2022.161 | Assessment of liver inflammation using glucose enhanced spin-lock T1rho MRI |
Prof. CHEN Weitian 陈蔚天 |
2022.205 | Retrospective review on paediatric and adolescent adnexal masses |
Dr. NG Karen 吳嘉詠 |
2022.190 | Individual patient data meta-analysis of medical treatment with timed surgery compared to immediate surgery in patients with acute type A intramural hematoma | Dr. CHOW Simon Chi Ying |
2022.152 | Combination of artificial intelligence (ENDOAID) and mucosal exposure device (ENDOCUFF) to enhance colorectal neoplasia detection: a randomized controlled trial | Prof. LAU Louis Ho Shing |
2022.160 | A prospective study to evaluate the diagnostic accuracy of computer-aided diagnosis (CADx) system in real-time characterization of colorectal neoplasia | Prof. LAU Louis Ho Shing |
2022.221 | Monitoring daily step activity of individuals with a lower limb prosthesis in the community of Hong Kong |
Mr. TSE Pak Hi 謝栢曦 |
2022.158 | The prevalence of Iron deficiency in Advanced Prostate Cancer Patients with Anaemia and the Impact on Patients |
Prof. NG Chi Fai 吳志輝 |
2022.185 | A double-blinded, randomised controlled trial to investigate the treatment effects of pulsed electromagnetic field (PEMF) on end stage of Knee Osteoarthritis |
Prof. ONG Michael Tim Yun 王添欣 |
2022.157 | Examining the health impact of extreme hot weather on older adults who are in socioeconomic disadvantage and those who are in long-term institutional care in Hong Kong |
Dr. LAI Tsz Chun 黎子俊 |
2022.186 | A Double-Blinded, Randomized-Controlled-Trial to Investigate the Effect of Pulsed Electromagnetic Field (PEMF) on quadriceps muscle strength for patients at 2 months after Anterior Cruciate Ligament Reconstruction (ACLR) |
Prof. ONG Michael Tim Yun 王添欣 |
2022.228 | Clinical application of serum anti-Müllerian hormone (AMH) measurements |
Dr. CHUNG Jacqueline Pui Wah 鍾佩樺 |
2022.200 | Right ventricular systolic dysfunction predicts poor outcomes after tricuspid valve surgery | Prof. LEE Alex Pui Wai |
2022.156 | Review of lung abscess manifestations and outcomes in a local hospital: a 20-year retrospective study | Dr. PANG Kit Hing |
2022.199 | Deep learning and radiomics algorithm of neuroimaging for TED in Hong Kong – A territory-wide study from the HADCL |
Dr. CHONG Kelvin Kam Lung 莊金隆 |
2022.150 | Effect of JAK inhibitor on bone erosion repair in rheumatoid arthritis assessed by HR-pQCT: a randomised placebo-controlled study |
Prof. SO Ho 蘇晧 |
2022.151 | Osteosarcopenia Assessed by 3D High-resolution Peripheral Quantitative Computed Tomography (HR-pQCT) and fracture risk in non-osteoporotic patients with immune-mediated inflammatory disease |
Prof. TAM Lai Shan 譚麗珊 |
Page 40 of 262.